🇺🇸 FDA
Pipeline program

long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations

BFH-NCRTPD

Phase 2 other active

Quick answer

long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations for Colorectal Neoplasms is a Phase 2 program (other) at BeOne Medicines with 1 ClinicalTrials.gov record(s).

Program details

Company
BeOne Medicines
Indication
Colorectal Neoplasms
Phase
Phase 2
Modality
other
Status
active

Clinical trials